Literature DB >> 29263446

Interventional cardiology: Operator technique is predictive of BVS-related adverse events.

Karina Huynh.   

Abstract

Year:  2017        PMID： 29263446     DOI： 10.1038/nrcardio.2017.217

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  2 in total

1.  3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.

Authors:  Dean J Kereiakes; Stephen G Ellis; Christopher Metzger; Ronald P Caputo; David G Rizik; Paul S Teirstein; Marc R Litt; Annapoorna Kini; Ameer Kabour; Steven O Marx; Jeffrey J Popma; Robert McGreevy; Zhen Zhang; Charles Simonton; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2017-10-31       Impact factor: 24.094

2.  Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation: Analysis From the ABSORB Trials.

Authors:  Gregg W Stone; Alexandre Abizaid; Yoshinobu Onuma; Ashok Seth; Runlin Gao; John Ormiston; Takeshi Kimura; Bernard Chevalier; Ori Ben-Yehuda; Ovidiu Dressler; Tom McAndrew; Stephen G Ellis; Dean J Kereiakes; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2017-10-31       Impact factor: 24.094
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.